Horse Chestnut Overview

1. Studied Conditions

Horse chestnut (Aesculus hippocastanum) has been studied for its potential effectiveness in treating several conditions, including:

• Chronic venous insufficiency (CVI)
• Varicose veins
• Hemorrhoids
• Post-surgery edema

2. Efficacy in Treating Conditions

Research suggests that horse chestnut seed extract may be effective in treating chronic venous insufficiency. Patients have experienced reduced leg swelling, pain, and itching. Evidence on the efficacy for other conditions such as varicose veins and hemorrhoids is less conclusive but still promising.

3. Health Benefits

The health benefits of horse chestnut are primarily associated with its vein-strengthening and anti-inflammatory properties. Benefits include:

• Improving vascular tone and blood flow
• Reducing leg swelling and discomfort from CVI
• Possibly reducing the size of varicose veins and hemorrhoids
• Antioxidant effects

4. Downsides

While horse chestnut can be beneficial, there are some downsides and precautions to consider:

• Raw horse chestnut seeds, leaves, flowers, and bark contain esculin, which is toxic and can lead to severe poisoning if ingested.
• Common side effects of horse chestnut extract include dizziness, headache, and gastrointestinal upset.
• It may interact with certain medications, such as blood thinners and diabetes drugs.
• Pregnant or breastfeeding women should avoid its use due to a lack of safety data.

5. Genetic Variations and Horse Chestnut

There is limited research on the interaction between horse chestnut and specific genetic variations. However, individuals with genetic conditions that affect bleeding or those who are genetically predisposed to liver issues should exercise caution due to potential increased risk of bleeding and liver toxicity. It is always recommended to consult with a healthcare provider before taking any new supplement, especially if there is a known genetic predisposition to certain health conditions.

Horse Chestnut (Aesculus hippocastanum) Research Summary

Therapeutic Effects of Aescin

Aescin, derived from the horse chestnut tree, has been effective in treating chronic venous insufficiency (CVI), hemorrhoids, and post-operative edema. It is comparable to compression therapy for CVI and has anti-inflammatory, anti-edematous, and venotonic properties that improve venous tension by facilitating ion channel entry. Aescin also releases PGF(2) from veins, antagonizes 5-HT and histamine, and reduces tissue mucopolysaccharide degradation.

Compound Isolation and Quantification

Three coumarins—scopoletin, esculetin, and fraxetin—were isolated from horse chestnut flowers and quantified using Ultra Performance Liquid Chromatography (UPLC).

Lipid Content of Horse Chestnut Fruit Oils

Horse chestnut fruit oils contain 81 g/kg of glyceride oil, 3 g/kg of phospholipids, 12 g/kg of sterols, and significant amounts of tocopherols. They are rich in essential fatty acids and biologically active substances, suggesting potential pharmaceutical and technical applications.

Flavonoid Content and Potential Uses

Flavonoids such as glycosides of quercetin and kaempferol are present in horse chestnut seeds. With 0.88% flavonoids by dry matter in powdered seeds, increasing to 9.40% after purification, these compounds offer medicinal qualities and could be sourced from industrial waste water for use in cosmetics and nutraceuticals.

Anti-Allergic Properties of Beta-Escin

Beta-escin exhibits anti-allergic effects, reducing allergic airway inflammation and mast cell activation in animal models. This suggests therapeutic potential for allergic diseases.

Therapeutic Potential for Hemorrhoidal Crisis

Emospid, containing a flavonoid and triterpene mixture, has shown to be effective and more efficient than MMDH tablets in treating acute hemorrhoidal crisis.

Pharmacokinetics of Escin

Research indicates that herbal preparations containing escin Ia and isoescin Ia may result in a longer duration of action than single isomers. The interconversion between isomers suggests that administering one isomer will lead to exposure to the other in the body.

Bioavailability of Beta-Aescin

No significant difference was found in the absorption rates of beta-aescin between standard and slow-release formulations, suggesting interchangeable use for delivering beta-aescin from horse chestnut seed extract.

Pharmacokinetics of Aescin in HCSE

Significant variability in the pharmacokinetics of beta-aescin from horse chestnut seed extract (HCSE) is observed, not due to study design or medication interference but due to natural variability in saponin content. The RIA method used for measuring beta-aescin may not be completely valid and requires specific validation or a more accurate LC-MS/MS method.

Anti-Tumor Effects of Escin Ia Transformation Products

Escin Ia, enzymatically transformed by human intestinal bacteria, produced desacylescin I which exhibited anti-tumor effects in mice.

References:

1. Aescin: pharmacology, pharmacokinetics and therapeutic profile
2. Coumarins in horse chestnut flowers: isolation and quantification by UPLC method
3. Lipid composition of Castanea sativa Mill. and Aesculus hippocastanum fruit oils
4. Aesculus hippocastanum (Horse chestnut). Monograph
5. Flavonoids in horse chestnut (Aesculus hippocastanum) seeds and powdered waste water byproducts
6. Flavonol oligosaccharides from the seeds of Aesculus hippocastanum
7. Flavonoids from the flowers of Aesculus hippocastanum
8. Beta-escin has potent anti-allergic efficacy and reduces allergic airway inflammation
9. Clinical effectiveness of a highly standardized and bioavailable mixture of flavonoids and triterpenes in the management of acute hemorroidal crisis
10. [Pharmacokinetic studies on triatiated aescin in the mouse and rat]
11. Comparative pharmacokinetics and bioavailability of escin Ia and isoescin Ia after administration of escin and of pure escin Ia and isoescin Ia in rat
12. Bioavailability of beta-aescin from horse chestnut seed extract: comparative clinical studies of two Galenic formulations
13. Measurement of the bioavailability of aescin-containing extracts
14. [Studies on the biotransformation of escin Ia by human intestinal bacteria and the anti-tumor activities of desacylescin I]
15. Roles of cytosolic Ca2+ concentration and myofilament Ca2+ sensitization in age-dependent cerebrovascular myogenic tone
16. Activation properties of chemically skinned fibres from human isolated bronchial smooth muscle
17. Mechanisms of angiotensin II-mediated decreases in intraneuronal Ca2+ in calcium-loaded stellate ganglion neurons
18. Enhancing effect of calmodulin on Ca(2+)-induced Ca2+ release in the sarcoplasmic reticulum of rabbit skeletal muscle fibres
19. Effects of beta-escin and saponin on the transverse-tubular system and sarcoplasmic reticulum membranes of rat and toad skeletal muscle
20. Effect of aescine on hypoxia-induced activation of human endothelial cells
21. Effect of aescine on hypoxia-induced neutrophil adherence to umbilical vein endothelium
22. Endothelium protectant and contractile effects of the antivaricose principle escin in rat aorta
23. Mechanism of action of some inhibitors of endothelium-derived relaxing factor
24. Effects of L-NAME on coronary blood flow, infarct size and the extent of the no-reflow phenomenon
25. Veinotonic effect, vascular protection, antiinflammatory and free radical scavenging properties of horse chestnut extract
26. Nitric oxide synthases: structure, function and inhibition
27. The mode of action of aescin and the release of prostaglandins
28. Venotonic activity of escin on the human saphenous vein
29. The mode of action of aescin on isolated veins: relationship with PGF2 alpha
30. The causes of skin damage and leg ulceration in chronic venous disease
31. The epidemiology of chronic venous insufficiency and varicose veins
32. Varicose veins and chronic venous insufficiency
33. Medical edema protection--clinical benefit in patients with chronic deep vein incompetence. A placebo controlled double blind study
34. Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency
35. [Evaluation of internally effective venous drugs]
36. [Demonstration of the effectiveness of the horse-chestnut-seed extract in the varicose syndrome complex]
37. Horse chestnut seed extract for chronic venous insufficiency
38. Compression therapy of the legs. A review
39. Comparative study of Venostasin and Pycnogenol in chronic venous insufficiency
40. O-(beta-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: an independent prospective comparative study
41. Hydroxyethylrutosides. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders
42. Effect of escin on adrenocorticotropin and corticosterone levels in rat plasma
43. Effects of beta-Aescin on the expression of nuclear factor-kappaB and tumor necrosis factor-alpha after traumatic brain injury in rats
44. Effects of sodium beta-aescin on expression of adhesion molecules and migration of neutrophils after middle cerebral artery occlusion in rats
45. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis
46. Escin exerts synergistic anti-inflammatory effects with low doses of glucocorticoids in vivo and in vitro
47. Synergistic protective effects of escin and low‑dose glucocorticoids on blood‑retinal barrier breakdown in a rat model of retinal ischemia
48. The allergic cascade: review of the most important molecules in the asthmatic lung
49. Mast-cell responses to pathogens
50. Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment:mouse models for the development of remedies for human allergic dermatitis
51. Mechanisms in allergic airway inflammation - lessons from studies in the mouse
52. Escin inhibits type I allergic dermatitis in a novel porcine model
53. Aescin and troxerutin as a successful combination for the treatment of inner ear perfusion disturbances
54. [Double blind study of reparil in proctology]
55. Hemorrhoids and varicose veins: a review of treatment options
56. Treatment of patients with venous insufficiency with fresh plant horse chestnut seed extract: a review of 5 clinical studies
57. Potential interactions between alternative therapies and warfarin
58. Benign renal tumors detected among healthy adults by abdominal ultrasonography
59. Angiomyolipoma of kidney
60. Life-threatening rupture of a renal angiomyolipoma in a patient taking over-the-counter horse chestnut seed extract
61. Contact urticaria due to aescin
62. Occupational asthma related to aescin inhalation

Upload Whole Genome Sequencing (WGS) raw DNA data today and take a deep dive into your genome!

Or if you only have standard microarray data currently, upload raw DNA data to get started with your free DNA raw data analysis today!